Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 207

1.

Why we will never work with the tobacco industry.

Hays JT, Hurt RD.

Addiction. 2019 May;114(5):934-935. doi: 10.1111/add.14582. Epub 2019 Mar 6. No abstract available.

PMID:
30746811
2.

Tobacco Dependence Treatment Grants: A Collaborative Approach to the Implementation of WHO Tobacco Control Initiatives.

Nolan MB, Kemper KE, Glynn TJ, Hurt RD, Hays JT.

J Environ Public Health. 2018 Mar 22;2018:8429738. doi: 10.1155/2018/8429738. eCollection 2018.

3.

Varenicline for tobacco-dependence treatment in alcohol-dependent smokers: A randomized controlled trial.

Hurt RT, Ebbert JO, Croghan IT, Schroeder DR, Hurt RD, Hays JT.

Drug Alcohol Depend. 2018 Mar 1;184:12-17. doi: 10.1016/j.drugalcdep.2017.11.017. Epub 2018 Jan 2.

4.

[The Mayo Clinic Nicotine Dependence Center].

Hurt RD, Hays TJ, Croghan IT.

Cas Lek Cesk. Winter 2017;156(1):17-18. Czech.

PMID:
28264576
5.

Response.

Hurt RD, Murphy JG, Dunn WF.

Chest. 2015 Jul;148(1):e30. doi: 10.1378/chest.15-0830. No abstract available.

PMID:
26149562
6.

Impact of a countywide smoke-free workplace law on emergency department visits for respiratory diseases: a retrospective cohort study.

Croghan IT, Ebbert JO, Hays JT, Schroeder DR, Chamberlain AM, Roger VL, Hurt RD.

BMC Pulm Med. 2015 Jan 22;15:6. doi: 10.1186/1471-2466-15-6.

8.

Combination varenicline and bupropion SR for tobacco-dependence treatment in cigarette smokers: a randomized trial.

Ebbert JO, Hatsukami DK, Croghan IT, Schroeder DR, Allen SS, Hays JT, Hurt RD.

JAMA. 2014 Jan 8;311(2):155-63. doi: 10.1001/jama.2013.283185.

9.

A randomized phase II clinical trial of high-dose nicotine patch therapy for smokeless tobacco users.

Ebbert JO, Croghan IT, Schroeder DR, Hurt RD.

Nicotine Tob Res. 2013 Dec;15(12):2037-44. doi: 10.1093/ntr/ntt097. Epub 2013 Jul 19.

10.

Smoking bans research--reply.

Hurt RD, Roger VL, Ebbert JO.

JAMA Intern Med. 2013 May 13;173(9):836-7. doi: 10.1001/jamainternmed.2013.928. No abstract available.

PMID:
23700023
11.

Myocardial infarction and sudden cardiac death in Olmsted County, Minnesota, before and after smoke-free workplace laws.

Hurt RD, Weston SA, Ebbert JO, McNallan SM, Croghan IT, Schroeder DR, Roger VL.

Arch Intern Med. 2012 Nov 26;172(21):1635-41.

12.

Tobacco dependence counseling in a randomized multisite clinical trial.

Croghan IT, Trautman JA, Winhusen T, Ebbert JO, Kropp FB, Schroeder DR, Hurt RD.

Contemp Clin Trials. 2012 Jul;33(4):576-82. doi: 10.1016/j.cct.2012.02.014. Epub 2012 Mar 3.

13.

Preventing lung cancer by treating tobacco dependence.

Hurt RD, Ebbert JO, Hays JT, McFadden DD.

Clin Chest Med. 2011 Dec;32(4):645-57. doi: 10.1016/j.ccm.2011.08.004. Review.

PMID:
22054877
14.

An exploration of site effects in a multisite trial of OROS-methylphenidate for smokers with attention deficit/hyperactivity disorder.

Covey LS, Hu MC, Green CA, Brigham G, Hurt RD, Adler L, Winhusen T.

Am J Drug Alcohol Abuse. 2011 Sep;37(5):392-9. doi: 10.3109/00952990.2011.596979.

15.

Roadmap to a tobacco epidemic: transnational tobacco companies invade Indonesia.

Hurt RD, Ebbert JO, Achadi A, Croghan IT.

Tob Control. 2012 May;21(3):306-12. doi: 10.1136/tc.2010.036814. Epub 2011 Aug 18.

16.

Zebrafish for the study of the biological effects of nicotine.

Klee EW, Ebbert JO, Schneider H, Hurt RD, Ekker SC.

Nicotine Tob Res. 2011 May;13(5):301-12. doi: 10.1093/ntr/ntr010. Epub 2011 Mar 8. Review.

17.

Residential treatment compared with outpatient treatment for tobacco use and dependence.

Hays JT, Croghan IT, Schroeder DR, Burke MV, Ebbert JO, McFadden DD, Hurt RD.

Mayo Clin Proc. 2011 Mar;86(3):203-9. doi: 10.4065/mcp.2010.0703. Epub 2011 Feb 9.

18.

Methylphenidate for treating tobacco dependence in non-attention deficit hyperactivity disorder smokers: a pilot randomized placebo-controlled trial.

Hurt RD, Ebbert JO, Croghan IT, Schroeder DR, Sood A, Hays JT.

J Negat Results Biomed. 2011 Jan 28;10:1. doi: 10.1186/1477-5751-10-1.

19.

Racial differences in smoking abstinence rates in a multicenter, randomized, open-label trial in the United States.

Croghan IT, Hurt RD, Ebbert JO, Croghan GA, Polk OD, Stella PJ, Novotny PJ, Sloan J, Loprinzi CL.

Z Gesundh Wiss. 2010 Feb;18(1):59-68. Epub 2009 Aug 11.

20.

Varenicline for smoking cessation: efficacy, safety, and treatment recommendations.

Ebbert JO, Wyatt KD, Hays JT, Klee EW, Hurt RD.

Patient Prefer Adherence. 2010 Oct 5;4:355-62.

21.

Varenicline for tobacco dependence treatment in recovering alcohol-dependent smokers: an open-label pilot study.

Hays JT, Croghan IT, Schroeder DR, Ebbert JO, Hurt RD.

J Subst Abuse Treat. 2011 Jan;40(1):102-7. doi: 10.1016/j.jsat.2010.08.009. Epub 2010 Oct 13.

PMID:
20947286
22.

Willingness of cancer patients to help family members to quit smoking.

Garces YI, Patten CA, Sinicrope PS, Decker PA, Offord KP, Brown PD, Clark MM, Rummans TA, Foote RL, Hurt RD.

Psychooncology. 2011 Jul;20(7):724-9. doi: 10.1002/pon.1768. Epub 2010 May 20.

PMID:
20878860
23.

Combination pharmacotherapy for stopping smoking: what advantages does it offer?

Ebbert JO, Hays JT, Hurt RD.

Drugs. 2010 Apr 16;70(6):643-50. doi: 10.2165/11536100-000000000-00000. Review.

24.

Legislating tolerance: Spain's national public smoking law.

Muggli ME, Lockhart NJ, Ebbert JO, Jiménez-Ruiz CA, Riesco Miranda JA, Hurt RD.

Tob Control. 2010 Feb;19(1):24-30. doi: 10.1136/tc.2009.031831. Epub 2009 Oct 21.

PMID:
19850551
25.

Treating tobacco dependence in a medical setting.

Hurt RD, Ebbert JO, Hays JT, McFadden DD.

CA Cancer J Clin. 2009 Sep-Oct;59(5):314-26. doi: 10.3322/caac.20031. Epub 2009 Aug 25.

26.

The role of smoking in breast cancer development: an analysis of a Mayo Clinic cohort.

Croghan IT, Pruthi S, Hays JT, Cha S, Johnson RE, Kosel M, Morris R, Hurt RD.

Breast J. 2009 Sep-Oct;15(5):489-95. doi: 10.1111/j.1524-4741.2009.00764.x. Epub 2009 Jul 13.

PMID:
19624417
27.

Feasibility of an exercise counseling intervention for depressed women smokers.

Vickers KS, Patten CA, Lewis BA, Clark MM, Ussher M, Ebbert JO, Croghan IT, Decker PA, Hathaway J, Marcus BH, Hurt RD.

Nicotine Tob Res. 2009 Aug;11(8):985-95. doi: 10.1093/ntr/ntp101. Epub 2009 Jun 18.

28.

A randomized, controlled trial of bupropion sustained-release for preventing tobacco relapse in recovering alcoholics.

Hays JT, Hurt RD, Decker PA, Croghan IT, Offord KP, Patten CA.

Nicotine Tob Res. 2009 Jul;11(7):859-67. doi: 10.1093/ntr/ntp077. Epub 2009 May 29.

29.

Open doorway to truth: legacy of the Minnesota tobacco trial.

Hurt RD, Ebbert JO, Muggli ME, Lockhart NJ, Robertson CR.

Mayo Clin Proc. 2009 May;84(5):446-56. doi: 10.1016/S0025-6196(11)60563-6. Review.

30.

Combination treatment with varenicline and nicotine replacement therapy.

Ebbert JO, Burke MV, Hays JT, Hurt RD.

Nicotine Tob Res. 2009 May;11(5):572-6. doi: 10.1093/ntr/ntp042. Epub 2009 Apr 7.

PMID:
19351781
31.

Varenicline and bupropion sustained-release combination therapy for smoking cessation.

Ebbert JO, Croghan IT, Sood A, Schroeder DR, Hays JT, Hurt RD.

Nicotine Tob Res. 2009 Mar;11(3):234-9. doi: 10.1093/ntr/ntn031. Epub 2009 Feb 25.

PMID:
19246427
32.

"Efforts to Reprioritise the Agenda" in China: British American Tobacco's Efforts to Influence Public Policy on Secondhand Smoke in China.

Muggli ME, Lee K, Gan Q, Ebbert JO, Hurt RD.

PLoS Med. 2008 Dec 23;5(12):1729-69. doi: 10.1371/journal.pmed.0050251.

33.

Urinary tobacco alkaloid measurement in patients having thromboangiitis obliterans.

Hurt RD, Hays JT.

Mayo Clin Proc. 2008 Oct;83(10):1187-8; author reply 1188. doi: 10.4065/83.10.1187-b. No abstract available.

PMID:
18828981
34.

Gender differences among smokers receiving interventions for tobacco dependence in a medical setting.

Croghan IT, Ebbert JO, Hurt RD, Hays JT, Dale LC, Warner N, Schroeder DR.

Addict Behav. 2009 Jan;34(1):61-7. doi: 10.1016/j.addbeh.2008.08.010. Epub 2008 Aug 31.

PMID:
18814974
35.

Study of the impact of laws regulating tobacco consumption on the prevalence of passive smoking in Spain.

Jiménez-Ruiz CA, Miranda JA, Hurt RD, Pinedo AR, Reina SS, Valero FC.

Eur J Public Health. 2008 Dec;18(6):622-5. doi: 10.1093/eurpub/ckn066. Epub 2008 Aug 2.

PMID:
18676987
36.

Waking a sleeping giant: the tobacco industry's response to the polonium-210 issue.

Muggli ME, Ebbert JO, Robertson C, Hurt RD.

Am J Public Health. 2008 Sep;98(9):1643-50. doi: 10.2105/AJPH.2007.130963. Epub 2008 Jul 16.

37.

British American Tobacco and the "insidious impact of illicit trade" in cigarettes across Africa.

Legresley E, Lee K, Muggli ME, Patel P, Collin J, Hurt RD.

Tob Control. 2008 Oct;17(5):339-46. doi: 10.1136/tc.2008.025999. Epub 2008 Jul 10. Review.

38.

Changes in readiness to quit and self-efficacy among adolescents receiving a brief office intervention for smoking cessation.

Patten CA, Decker PA, Dornelas EA, Barbagallo J, Rock E, Offord KP, Hurt RD, Pingree S.

Psychol Health Med. 2008 May;13(3):326-36. doi: 10.1080/13548500701426703.

PMID:
18569900
39.

Change in perceived stress, partner support, decisional balance, and self-efficacy following residential nicotine dependence treatment.

Ames SC, Croghan IT, Clark MM, Patten CA, Stevens SR, Schroeder DR, Eberman KM, Hays JT, Hurt RD.

J Addict Dis. 2008;27(1):73-82. doi: 10.1300/J069v27n01_08.

PMID:
18551890
40.

Development and feasibility of a parental support intervention for adolescent smokers.

Ames SC, Rock E, Hurt RD, Patten CA, Croghan IT, Stoner SM, Decker PA, Offord KP, Nelson M.

Subst Use Misuse. 2008;43(3-4):497-511. doi: 10.1080/10826080701208426.

PMID:
18365946
41.

Tobacco use and cessation among pregnant Alaska Natives from Western Alaska enrolled in the WIC program, 2001-2002.

Patten CA, Renner CC, Decker PA, O'Campo E, Larsen K, Enoch C, Offord KP, Hurt RD, Lanier A, Kaur J.

Matern Child Health J. 2008 Jul;12 Suppl 1:30-6. doi: 10.1007/s10995-008-0331-7. Epub 2008 Mar 14.

42.

Focus groups of Alaska Native adolescent tobacco users: preferences for tobacco cessation interventions and barriers to participation.

Patten CA, Enoch C, Renner CC, Offord KP, Nevak C, Kelley SF, Thomas J, Decker PA, Hurt RD, Lanier A, Kaur JS.

Health Educ Behav. 2009 Aug;36(4):711-23. Epub 2007 Nov 29.

43.

Cough following initiation of smoking abstinence.

Warner DO, Colligan RC, Hurt RD, Croghan IT, Schroeder DR.

Nicotine Tob Res. 2007 Nov;9(11):1207-12.

PMID:
17978996
44.

Second primary tumors following tobacco dependence treatments among head and neck cancer patients.

Garces YI, Schroeder DR, Nirelli LM, Croghan GA, Croghan IT, Foote RL, Hurt RD.

Am J Clin Oncol. 2007 Oct;30(5):531-9.

PMID:
17921716
45.
46.

Treating tobacco dependence: review of the best and latest treatment options.

Ebbert JO, Sood A, Hays JT, Dale LC, Hurt RD.

J Thorac Oncol. 2007 Mar;2(3):249-56. Review.

47.

Tobacco and other substance use among Alaska Native youth in western Alaska.

Angstman S, Patten CA, Renner CC, Simon A, Thomas JL, Hurt RD, Schroeder DR, Decker PA, Offord KP.

Am J Health Behav. 2007 May-Jun;31(3):249-60.

PMID:
17402865
48.

Nicotine lozenges for the treatment of smokeless tobacco use.

Ebbert JO, Dale LC, Severson H, Croghan IT, Rasmussen DF, Schroeder DR, Vander Weg MW, Hurt RD.

Nicotine Tob Res. 2007 Feb;9(2):233-40.

PMID:
17365754
49.

Expressive writing as a smoking cessation treatment adjunct for young adult smokers.

Ames SC, Patten CA, Werch CE, Schroeder DR, Stevens SR, Fredrickson PA, Echols JD, Pennebaker JW, Hurt RD.

Nicotine Tob Res. 2007 Feb;9(2):185-94.

PMID:
17365749
50.

Effect of high-dose nicotine patch therapy on tobacco withdrawal symptoms among smokeless tobacco users.

Ebbert JO, Dale LC, Patten CA, Croghan IT, Schroeder DR, Moyer TP, Hurt RD.

Nicotine Tob Res. 2007 Jan;9(1):43-52.

PMID:
17365735

Supplemental Content

Support Center